Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02601014
Brief Title: Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7 (STARVE-PC)

First Submitted : August 21, 2015
First Submitted that Met QC Criteria : November 6, 2015
First Posted : November 10, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : September 24, 2019
Last Update Posted : September 26, 2019